Bulahan, Allea Claire B.

HRN: 26-33-70  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
12/06/2024
12/13/2024
PO
3.5 ML
Q8h
UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: